|
US2009238812A1
|
|
Method for the early indentification and prediction of an abrupt reduction in kidney function in a patient undergoing cardiothoracic surgery
|
|
WO2009116021A1
|
|
Method of assessing kidney function in a human subject
|
|
US2009239242A1
|
|
Method for the early identification and prediction of kidney injury
|
|
WO2008072216A1
|
|
A method for detecting human parvovirus antigen
|
|
GB0422081D0
|
|
Stabilising dilutent for hrp conjugates
|
|
IE20040661A1
|
|
Stabilising diluent for a protein-horseradish peroxidase conjugate
|
|
IES20040662A2
|
|
Stabilising diluent for a protein-horseradish peroxidase conjugate
|
|
GB0411389D0
|
|
Process for preparing a liquid stable, ready-to-use diluent for a protein-enzyme conjugate
|
|
IES20040343A2
|
|
Process for preparing a liquid stable, ready-to-use diluent for a protein-enzyme conjugate
|
|
IE20040344A1
|
|
Process for preparing a liquid stable, ready-to-use diluent for a protein-enzyme conjugate
|
|
US6669939B1
|
|
(Poly)peptides which represent the epitopes of the human herpes virus type 8
|
|
CN1180411A
|
|
Rapid assays for assessment of orgen status based on detection of one or more isoenzymes of glutathione S-transferase
|
|
CN1208465A
|
|
Method of determining the hepatic status of an individual, including a liver transplant recipient
|
|
AU4632396A
|
|
Method of determining the hepatic status of an individual, including a liver transplant recipient
|
|
HUT78056A
|
|
Method of determining or detecting donor organ damage following xenotransplantation based on donor organ-derived analytes
|
|
CN1205081A
|
|
Method of determining or detecting donor organ demage following xenotransplantation based on donor organ-derived analytes
|
|
CA2202773A1
|
|
Stabilising medium for .alpha.gst in urine for use in an enzyme immunoassay
|
|
IES940826A2
|
|
Stabilising medium for antibody-enzyme conjugates
|
|
AU7821994A
|
|
Stabilising medium for alphaGST in urine for use in an enzyme immunoassay
|
